Acuity (AYI) reported $1.14 billion in revenue for the quarter ended November 2025, representing a year-over-year increase of 20.2%. EPS of $4.69 for the same period compares to $3.97 a year ago.The reported revenue represents a surprise of +0.53% over the Zacks Consensus Estimate of $1.14 billion. With the consensus EPS estimate being $4.52, the company has not delivered EPS surprise.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to ...

U.S. stocks traded lower this morning, with the Nasdaq Composite falling more than 100 points on Thursday.Following the market opening Thursday, the Dow traded down 0.05% to 48,972.29 while the NASDAQ declined 0.57% to 23,448.86. The S&P 500 also fell, dropping, 0.14% to 6,911.57.Check This Out: Delta Air Lines Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings CallLeading and Lagging SectorsIndustrials shares gained by 1.4% on Thursday.In trading on Thursday, information ...

Helen of Troy Limited (NASDAQ:HELE) will release earnings results for its third quarter before the opening bell on Thursday, Jan. 8, 2025.Analysts expect the El Paso, Texas-based company to report quarterly earnings at $1.68 per share, down from $2.67 per share in the year-ago period. The consensus estimate for Helen of Troy's quarterly revenue is $502.17 million, up from $530.71 million a year earlier, according to data from Benzinga Pro.On Nov. 25, Helen of Troy announced amendment to existing credit agre ...

A month has gone by since the last earnings report for Toll Brothers (TOL) . Shares have added about 2.3% in that time frame, outperforming the S&P 500.But investors have to be wondering, will the recent positive trend continue leading up to its next earnings release, or is Toll Brothers due for a pullback? Well, first let's take a quick look at its most recent earnings report in order to get a better handle on the recent drivers for Toll Brothers Inc. before we dive into how investors and analysts have rea ...

Core Insights - AngioDynamics reported a Q2 2026 EPS of -$0.15, missing the estimated -$0.10, but exceeded revenue expectations with $79.43 million compared to the estimated $76.7 million [1][6] - The company experienced double-digit growth in its medical technology segment, contributing to increased profitability despite a negative P/E ratio of approximately -14.67 [2][6] - AngioDynamics raised its fiscal year 2026 adjusted EPS guidance, indicating a positive outlook for future performance, although shares declined by 1.8% to close at $12.87 [4][6] Financial Performance - Analysts had forecasted a quarterly loss of 10 cents per share, which is deeper than the 4 cents per share loss from the same quarter last year [3] - Revenue of $79.43 million surpassed the previous year's $72.84 million, indicating a positive trend in sales [3] - The company's price-to-sales ratio of about 1.56 suggests that investors are paying $1.56 for every dollar of sales, reflecting confidence in its revenue-generating capabilities [3] Analyst Sentiment - Canaccord Genuity analyst William Plovanic maintained a Buy rating and increased the price target from $17 to $18, indicating positive sentiment from analysts regarding the company's potential [4] - Despite financial challenges, the company maintains a strong current ratio of about 2.29, suggesting solid ability to cover short-term liabilities with short-term assets [5]

Valued at a market cap of $49.6 billion, Marathon Petroleum Corporation (MPC) is an integrated downstream energy company based in Findlay, Ohio. It operates a nationwide network of refineries with significant capacity to process crude oil into gasoline, diesel, jet fuel, and other refined products. The company is expected to announce its fiscal Q4 earnings for 2025 on Tuesday, Feb. 3. Ahead of this event, analysts expect this energy company to report a profit of $3.73 per share, up 384.4% from $0.77 per ...

With a market cap of $14.1 billion, Avery Dennison Corporation (AVY) is a global materials science and digital identification solutions company that provides pressure-sensitive labeling materials, performance tapes, graphics and reflective products, and branding and information solutions across multiple industries. The company serves markets worldwide, including retail, apparel, logistics, food, pharmaceuticals, and automotive. The Mentor, Ohio-based company is set to release its fiscal Q4 2025 results s ...

Revvity, Inc. (RVTY) is a Massachusetts-based life sciences and diagnostics company formed in 2023. It provides instruments, reagents, software, informatics, and testing platforms used by pharmaceutical and biotech firms, research institutions, clinical labs, public health organizations and governments to support genetic screening, infectious disease testing, biomarker discovery, multi-omics science, and broader life sciences workflows. It is currently valued at $11.1 billion by market cap. The healthcar ...

Franklin Covey Co. (NYSE:FC) will release earnings results for its first quarter after the closing bell on Wednesday, Jan. 7, 2025.Analysts expect the Draper, Utah-based company to report quarterly earnings at 13 cents per share, down from 20 cents per share in the year-ago period. The consensus estimate for Franklin Covey's quarterly revenue is $64.77 million, up from $69.09 million a year earlier, according to Benzinga Pro data.On Nov. 5, Franklin Covey posted mixed results for the fourth quarter.Shares o ...

Valued at $96.8 billion by market cap, Altria Group, Inc. (MO) is a leading tobacco company and consumer staples holding firm headquartered in Richmond, Virginia. It is one of the largest manufacturers and marketers of smokeable and oral tobacco products in the United States, with its most prominent brands including Marlboro cigarettes, Black & Mild cigars, and smokeless tobacco products such as Copenhagen and Skoal. Altria Group is ready to release its fourth-quarter results soon. Ahead of the event, an ...